Enochian Biosciences
ENOB
$0.70
Share price
0.00%
Change (1 day)
-74.17%
Change (1 year)
Categories
Enochian Biosciences (ENOB) - P/B ratio
P/B ratio as of May 2024 : 0.6743
According to Enochian Biosciences's latest financial reports the company has a price-to-book ratio of 0.6743.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Enochian Biosciences - P/B ratio (from 2015 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 0.7510 | -67.58% |
| 2021-12-31 | 2.32 | 171.96% |
| 2020-12-31 | 0.8519 | -37.23% |
| 2019-12-31 | 1.36 | -25.67% |
| 2018-12-31 | 1.83 | -94.81% |
| 2017-12-31 | 35.2 | -416.06% |
| 2016-12-31 | -11.1 | -113.23% |
| 2015-12-31 | 84.2 | |
| 2014-12-31 | N/A | |
| 2013-12-31 | N/A | |
| 2012-12-31 | N/A | |
| 2011-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.76 | 308.74% | 🇺🇸 USA |